EZH2 and hepatocellular carcinoma: A study has revealed that HBx not only inhibits the mRNA expression level of AIM2 by stabilizing the enhancer of zeste homolog 2 (EZH2), but also promotes AIM2 protein degradation in a proteasome-dependent manner in HBV-infected hepatocellular carcinoma (HCC) cells [107].